1486 related articles for article (PubMed ID: 28826735)
1. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
2. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
[TBL] [Abstract][Full Text] [Related]
3. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
4. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
5. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
[TBL] [Abstract][Full Text] [Related]
6. Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.
Cenderello G; De Maria A
Expert Rev Anti Infect Ther; 2016; 14(1):29-40. PubMed ID: 26513236
[TBL] [Abstract][Full Text] [Related]
7. Determinants of suboptimal CD4
Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
[TBL] [Abstract][Full Text] [Related]
8. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
10. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters.
Guo FP; Li YJ; Qiu ZF; Lv W; Han Y; Xie J; Li YL; Song XJ; Du SS; Mehraj V; Li TS; Routy JP
Chin Med J (Engl); 2016 Nov; 129(22):2683-2690. PubMed ID: 27824000
[TBL] [Abstract][Full Text] [Related]
11. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
[TBL] [Abstract][Full Text] [Related]
12. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
[TBL] [Abstract][Full Text] [Related]
13. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
[TBL] [Abstract][Full Text] [Related]
14. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
[TBL] [Abstract][Full Text] [Related]
15. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
[TBL] [Abstract][Full Text] [Related]
16. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
[TBL] [Abstract][Full Text] [Related]
17. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
18. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
19. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
Horta A; Nobrega C; Amorim-Machado P; Coutinho-Teixeira V; Barreira-Silva P; Boavida S; Costa P; Sarmento-Castro R; Castro AG; Correia-Neves M
PLoS One; 2013; 8(2):e57336. PubMed ID: 23437372
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
Wang Y; Zhang Y; Tang T; Zhao W; Fu S; Zhang Z; Fu Y; Xu J; Ding H; Han X; Jiang Y
Virology; 2020 Nov; 550():89-98. PubMed ID: 32920454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
